GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Oxford BioDynamics PLC (LSE:OBD) » Definitions » 5-Year EBITDA Growth Rate

Oxford BioDynamics (LSE:OBD) 5-Year EBITDA Growth Rate : -5.90% (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Oxford BioDynamics 5-Year EBITDA Growth Rate?

Oxford BioDynamics's EBITDA per Share for the six months ended in Sep. 2024 was £-0.02.

During the past 3 years, the average EBITDA Per Share Growth Rate was 16.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -5.90% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -8.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of Oxford BioDynamics was 32.30% per year. The lowest was -42.20% per year. And the median was -11.60% per year.


Competitive Comparison of Oxford BioDynamics's 5-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Oxford BioDynamics's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford BioDynamics's 5-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Oxford BioDynamics's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Oxford BioDynamics's 5-Year EBITDA Growth Rate falls into.


;
;

Oxford BioDynamics 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Oxford BioDynamics  (LSE:OBD) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Oxford BioDynamics 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford BioDynamics Business Description

Traded in Other Exchanges
Address
John Smith Drive, 3140 Rowan Place, ARC Oxford, Oxford, GBR, OX4 2WB
Oxford BioDynamics PLC is a biotechnology company engaged in developing and commercializing precision clinical diagnostic tests for life-changing diseases. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The tests are based on the company's proprietary 3D genomic biomarker platform, EpiSwitch which enables screening, evaluation, validation, and monitoring of biomarkers. In addition, the company offers, EpiSwitch Explorer Array Kit for 3D genome profiling. It is also developing new tests in the areas of oncology, neurology, inflammation, hepatology, and animal health. Geographically, it derives key revenue from the United States of America.

Oxford BioDynamics Headlines

No Headlines